campaign
Sun Pharma Ilumya — Global Specialty Growth
- Location
- Mumbai + Global
- Dates
- January 1, 2023 – June 30, 2025
Sun Pharma's Ilumya has become a leading biologic for plaque psoriasis, with growing international expansion and additional indication trials underway. The specialty business overall — Ilumya, Cequa, Odomzo, and Winlevi — is central to Sun's strategy of moving beyond commodity generics to higher-margin innovative medicines, tracked by pharma-industry analysts and specialty medicine writers globally.
Credits (2)
